Mometasone Viatris (Mometasone Furoate)

Mometasone furoate, the active ingredient in Mometasone Viatris, is a corticosteroid presented as a nasal spray for intranasal use. It reduces inflammation in the nasal passages and is indicated for allergic rhinitis and nasal polyps in adults and children. The drug exerts local anti‑inflammatory effects with minimal systemic absorption, providing symptom relief such as reduced congestion, itching and sneezing.

GNH USA supplies Mometasone Viatris as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies, clinics and research institutions worldwide, delivering products globally.

Mometasone furoate nasal spray acts on inflammatory pathways of the nasal mucosa to relieve symptoms of allergic and obstructive nasal conditions.

Allergic rhinitis: alleviates nasal congestion, itching, sneezing and watery discharge, providing rapid symptom control in seasonal and perennial allergy sufferers. Nasal polyps: reduces polyp size and associated inflammation, leading to improved nasal patency and decreased need for surgical intervention.

Mometasone furoate nasal spray may cause local and, rarely, systemic adverse reactions.

Common Side Effects: - Nasal irritation or burning sensation - Epistaxis (nosebleeds) - Headache - Throat irritation or dryness - Cough - Altered taste perception

Serious or Rare Side Effects: - Adrenal suppression with prolonged high‑dose use - Severe nasal septal perforation - Vision changes or cataract formation - Opportunistic fungal infection of the nasal passages - Anaphylaxis or severe allergic reaction - Growth suppression in pediatric patients

Before initiating therapy, consider the following precautions.

Screen for active nasal infection: avoid use in untreated bacterial or fungal sinusitis. Monitor for adrenal effects: assess for signs of systemic corticosteroid exposure, especially with prolonged use. Use with caution in children: monitor growth velocity during therapy. Avoid abrupt discontinuation: taper dose to prevent rebound inflammation. Assess for hypersensitivity: discontinue if allergic reaction occurs. Store at room temperature: keep in original packaging, protect from moisture and heat.

Mometasone furoate nasal spray can interact with other medicines; review the following.

Major Interactions (Avoid): - Systemic corticosteroids: concurrent use may increase risk of systemic glucocorticoid effects. - Strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole): may raise local mometasone exposure.

Moderate Interactions (Monitor Closely): - Antihistamines: may increase local irritation but are generally safe. - Nasal decongestant sprays: concurrent use may affect mucosal absorption. - Immunosuppressants: monitor for additive immunosuppression. - Ritonavir: potential increase in corticosteroid levels.